首页> 外文期刊>Neurochemistry International: The International Journal for the Rapid Publication of Critical Reviews, Preliminary and Original Research Communications in Neurochemistry >The novel alpha 2-adrenoceptor agonist (3H)mivazerol binds to non-adrenergic binding sites in human striatum membranes that are distinct from imidazoline receptors.
【24h】

The novel alpha 2-adrenoceptor agonist (3H)mivazerol binds to non-adrenergic binding sites in human striatum membranes that are distinct from imidazoline receptors.

机译:新型的α2-肾上腺素受体激动剂(3H)mivazerol与人纹状体膜中的非肾上腺素结合位点结合,与咪唑啉受体不同。

获取原文
获取原文并翻译 | 示例
       

摘要

The alpha 2 adrenergic agonist [3H]mivazerol labelled two populations of binding sites in membranes from the human striatum. Forty per cent of the sites labelled by 3 nM [3H]mivazerol corresponded to alpha 2 adrenergic receptors as they displayed a high affinity for (-)-adrenaline and for rauwolscine. The remaining binding was displaced by mivazerol with a pIC50 of 6.5 +/- 0.1. These sites displayed higher affinity for dexmedetomidine (pIC50 = 7.1 +/- 0.1), but much lower affinity for clonidine (pIC50 < 5.0) and for idazoxan (pIC50 = 5.1 +/- 0.1). Mivazerol also showed low affinity for the [3H]clonidine-labelled I1 imidazoline receptors and for the [3H]idazoxan-labelled I2 receptors (pIC50 = 5.1 and 3.9, respectively). These results suggest that the non-adrenergic [3H]mivazerol binding sites are distinct from the imidazoline receptors in the human striatum.
机译:α2肾上腺素能激动剂[3H]米瓦零醇标记了人纹状体膜中的两个结合位点群体。 3 nM [3H] mivazerol标记的位点中有40%对应于α2肾上腺素能受体,因为它们显示出对(-)-肾上腺素和对劳伍素的高度亲和力。剩余的结合物被米伐诺尔置换,pIC50为6.5 +/- 0.1。这些位点显示出对右美托咪定的亲和力较高(pIC50 = 7.1 +/- 0.1),但对可乐定的亲和力较低(pIC50 <5.0)和对异唑烷的亲和力较低(pIC50 = 5.1 +/- 0.1)。 Mivazerol对[3H]可乐定标记的I1咪唑啉受体和[3H]咪唑并恶唑标记的I2受体也显示出低亲和力(分别为pIC50 = 5.1和3.9)。这些结果表明,在人类纹状体中,非肾上腺素[3H]米瓦零醇结合位点与咪唑啉受体不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号